Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYH9 ABCF1 ZCWPW2 ATRX ABCA6 DNAH6 ABCA10 ABCA9 SLC27A4	7.38e-05	614	59	9	GO:0140657
GeneOntologyMolecularFunction	chromatin binding	ATRX ACTR6 PARP2 DPPA2 NSD1 POU5F1 TTF1 TOP1 CREB3L1	2.97e-04	739	59	9	GO:0003682
GeneOntologyMolecularFunction	histone H3K14 acetyltransferase activity	JADE1 BRD1	3.05e-04	9	59	2	GO:0036408
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA6 ABCA10 ABCA9	4.10e-04	49	59	3	GO:0140359
GeneOntologyMolecularFunction	histone H4K8 acetyltransferase activity	JADE1 BRD1	4.64e-04	11	59	2	GO:0043996
GeneOntologyMolecularFunction	histone H4K5 acetyltransferase activity	JADE1 BRD1	4.64e-04	11	59	2	GO:0043995
GeneOntologyMolecularFunction	histone H4K12 acetyltransferase activity	JADE1 BRD1	5.56e-04	12	59	2	GO:0043997
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	JADE1 BRD1	8.79e-04	15	59	2	GO:0010484
GeneOntologyMolecularFunction	5'-3' exonuclease activity	XRN1 DCLRE1A	1.27e-03	18	59	2	GO:0008409
GeneOntologyMolecularFunction	polypeptide N-acetylgalactosaminyltransferase activity	GALNT17 GALNT5	1.58e-03	20	59	2	GO:0004653
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCF1 ATRX ABCA6 DNAH6 ABCA10 ABCA9	1.88e-03	441	59	6	GO:0016887
GeneOntologyMolecularFunction	clathrin adaptor activity	AP2A1 AP2A2	1.91e-03	22	59	2	GO:0035615
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCF1 RGS6 ATRX ABCA6 DNAH6 ABCA10 ABCA9 MMUT	1.91e-03	775	59	8	GO:0017111
GeneOntologyMolecularFunction	HMG box domain binding	PRRX1 POU5F1	2.09e-03	23	59	2	GO:0071837
GeneOntologyMolecularFunction	histone H4 acetyltransferase activity	JADE1 BRD1	2.09e-03	23	59	2	GO:0010485
GeneOntologyMolecularFunction	cargo adaptor activity	AP2A1 AP2A2	2.46e-03	25	59	2	GO:0140312
GeneOntologyMolecularFunction	lipid transporter activity	ABCA6 ABCA10 ABCA9 SLC27A4	2.69e-03	196	59	4	GO:0005319
GeneOntologyMolecularFunction	pyrophosphatase activity	ABCF1 RGS6 ATRX ABCA6 DNAH6 ABCA10 ABCA9 MMUT	3.12e-03	839	59	8	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ABCF1 RGS6 ATRX ABCA6 DNAH6 ABCA10 ABCA9 MMUT	3.15e-03	840	59	8	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ABCF1 RGS6 ATRX ABCA6 DNAH6 ABCA10 ABCA9 MMUT	3.15e-03	840	59	8	GO:0016818
GeneOntologyMolecularFunction	modification-dependent protein binding	ZCWPW2 ATRX PARP2 POU5F1	3.21e-03	206	59	4	GO:0140030
GeneOntologyBiologicalProcess	chromatin remodeling	TET2 ATRX ACTR6 PARP2 DPPA2 NSD1 JADE1 BRD1 TTF1 TOP1	5.00e-05	741	60	10	GO:0006338
GeneOntologyBiologicalProcess	neuronal stem cell population maintenance	PRRX1 ASPM PCM1	5.80e-05	26	60	3	GO:0097150
GeneOntologyBiologicalProcess	regulation of asymmetric cell division	ASPM POU5F1	8.27e-05	5	60	2	GO:0009786
GeneOntologyCellularComponent	fibrillar center	RNMT DCLRE1A TTF1 THAP1 TOP1	8.51e-05	156	60	5	GO:0001650
MousePheno	abnormal respiratory function	PRRX1 NALCN SLIT3 GREM1 SUCO TSLP MMUT SLC27A4	2.07e-05	399	42	8	MP:0002327
MousePheno	herniated abdominal wall	RPL38 SLIT3 SLC27A4	2.77e-05	20	42	3	MP:0000757
MousePheno	abnormal breathing pattern	PRRX1 NALCN SLIT3 GREM1 SUCO MMUT SLC27A4	2.95e-05	303	42	7	MP:0001951
MousePheno	respiratory distress	PRRX1 SLIT3 GREM1 SUCO MMUT SLC27A4	3.04e-05	204	42	6	MP:0001954
MousePheno	abnormal metacarpal bone morphology	PRRX1 RPL38 GREM1	1.83e-04	37	42	3	MP:0003073
Domain	ZF_PHD_2	ATRX PHF12 NSD1 PHF7 JADE1 BRD1	5.35e-07	95	59	6	PS50016
Domain	ZF_PHD_1	ATRX PHF12 NSD1 PHF7 JADE1 BRD1	5.70e-07	96	59	6	PS01359
Domain	ABC_A	ABCA6 ABCA10 ABCA9	6.46e-06	12	59	3	IPR026082
Domain	Znf_FYVE_PHD	ATRX PHF12 NSD1 PHF7 JADE1 BRD1	6.86e-06	147	59	6	IPR011011
Domain	PHD	PHF12 NSD1 PHF7 JADE1 BRD1	8.97e-06	89	59	5	SM00249
Domain	-	AP2A1 AP2A2	9.81e-06	2	59	2	2.60.40.1030
Domain	AP2_complex_asu	AP2A1 AP2A2	9.81e-06	2	59	2	IPR017104
Domain	Clathrin_a-adaptin_app_sub_C	AP2A1 AP2A2	9.81e-06	2	59	2	IPR003164
Domain	Clathrin_a-adaptin_app_Ig-like	AP2A1 AP2A2	9.81e-06	2	59	2	IPR013038
Domain	Alpha_adaptin_C	AP2A1 AP2A2	9.81e-06	2	59	2	PF02296
Domain	Znf_PHD	PHF12 NSD1 PHF7 JADE1 BRD1	1.00e-05	91	59	5	IPR001965
Domain	ABC_tran	ABCF1 ABCA6 ABCA10 ABCA9	1.58e-05	48	59	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCF1 ABCA6 ABCA10 ABCA9	1.58e-05	48	59	4	PS50893
Domain	ABC_TRANSPORTER_1	ABCF1 ABCA6 ABCA10 ABCA9	1.71e-05	49	59	4	PS00211
Domain	ABC_transporter-like	ABCF1 ABCA6 ABCA10 ABCA9	1.86e-05	50	59	4	IPR003439
Domain	EPHD	PHF7 JADE1 BRD1	4.42e-05	22	59	3	PS51805
Domain	PWWP	ZCWPW2 NSD1 BRD1	5.07e-05	23	59	3	PF00855
Domain	PWWP_dom	ZCWPW2 NSD1 BRD1	5.07e-05	23	59	3	IPR000313
Domain	Zinc_finger_PHD-type_CS	PHF12 NSD1 JADE1 BRD1	5.27e-05	65	59	4	IPR019786
Domain	PWWP	ZCWPW2 NSD1 BRD1	5.78e-05	24	59	3	PS50812
Domain	-	AP2A1 AP2A2	5.86e-05	4	59	2	3.30.310.30
Domain	Clathrin_a/coatomer_app_sub_C	AP2A1 AP2A2	5.86e-05	4	59	2	IPR015873
Domain	AAA+_ATPase	ABCF1 ABCA6 DNAH6 ABCA10 ABCA9	9.10e-05	144	59	5	IPR003593
Domain	AAA	ABCF1 ABCA6 DNAH6 ABCA10 ABCA9	9.10e-05	144	59	5	SM00382
Domain	PHD	PHF12 NSD1 JADE1 BRD1	9.23e-05	75	59	4	PF00628
Domain	Znf_PHD-finger	PHF12 NSD1 JADE1 BRD1	1.13e-04	79	59	4	IPR019787
Domain	Coatomer/calthrin_app_sub_C	AP2A1 AP2A2	2.71e-04	8	59	2	IPR009028
Domain	EPL1	JADE1 BRD1	2.71e-04	8	59	2	PF10513
Domain	Enhancer_polycomb-like_N	JADE1 BRD1	2.71e-04	8	59	2	IPR019542
Domain	Clathrin_a/b/g-adaptin_app_Ig	AP2A1 AP2A2	3.48e-04	9	59	2	IPR008152
Domain	Alpha_adaptinC2	AP2A1 AP2A2	3.48e-04	9	59	2	PF02883
Domain	Alpha_adaptinC2	AP2A1 AP2A2	3.48e-04	9	59	2	SM00809
Domain	-	ATRX PHF12 NSD1 PHF7 MIB2 JADE1 BRD1	5.14e-04	449	59	7	3.30.40.10
Domain	Znf_RING/FYVE/PHD	ATRX PHF12 NSD1 PHF7 MIB2 JADE1 BRD1	5.85e-04	459	59	7	IPR013083
Domain	Coatomer/clathrin_app_Ig-like	AP2A1 AP2A2	6.34e-04	12	59	2	IPR013041
Domain	NPIP	NPIPB8 NPIPB6	8.71e-04	14	59	2	IPR009443
Domain	Clathrin/coatomer_adapt-like_N	AP2A1 AP2A2	1.00e-03	15	59	2	IPR002553
Domain	Adaptin_N	AP2A1 AP2A2	1.00e-03	15	59	2	PF01602
Domain	POU	POU6F2 POU5F1	1.14e-03	16	59	2	SM00352
Domain	POU_2	POU6F2 POU5F1	1.14e-03	16	59	2	PS00465
Domain	POU_dom	POU6F2 POU5F1	1.14e-03	16	59	2	IPR000327
Domain	POU_3	POU6F2 POU5F1	1.14e-03	16	59	2	PS51179
Domain	Pou	POU6F2 POU5F1	1.14e-03	16	59	2	PF00157
Domain	POU_1	POU6F2 POU5F1	1.14e-03	16	59	2	PS00035
Domain	POU	POU6F2 POU5F1	1.29e-03	17	59	2	IPR013847
Domain	IQ	MYH9 IQGAP2 ASPM	1.47e-03	71	59	3	PF00612
Domain	ARM-like	AP2A1 AP2A2 ASPM USP9Y HOMEZ	1.61e-03	270	59	5	IPR011989
Domain	Myosin-like_IQ_dom	MYH9 ASPM	1.62e-03	19	59	2	IPR027401
Domain	-	MYH9 ASPM	1.62e-03	19	59	2	4.10.270.10
Domain	PWWP	NSD1 BRD1	1.80e-03	20	59	2	SM00293
Domain	-	POU6F2 PRRX1 POU5F1 TTF1 HOMEZ	1.98e-03	283	59	5	1.10.10.60
Domain	-	DPPA2 SF3B2	1.98e-03	21	59	2	1.10.720.30
Domain	IQ	MYH9 IQGAP2 ASPM	2.14e-03	81	59	3	SM00015
Domain	CT	SLIT3 GREM1	2.18e-03	22	59	2	SM00041
Domain	SAP	DPPA2 SF3B2	2.38e-03	23	59	2	SM00513
Domain	SAP	DPPA2 SF3B2	2.81e-03	25	59	2	PS50800
Domain	Ricin_B_lectin	GALNT17 GALNT5	2.81e-03	25	59	2	PF00652
Domain	Cys_knot_C	SLIT3 GREM1	2.81e-03	25	59	2	IPR006207
Domain	SAP_dom	DPPA2 SF3B2	2.81e-03	25	59	2	IPR003034
Domain	CTCK_2	SLIT3 GREM1	2.81e-03	25	59	2	PS01225
Domain	IQ_motif_EF-hand-BS	MYH9 IQGAP2 ASPM	2.89e-03	90	59	3	IPR000048
Domain	IQ	MYH9 IQGAP2 ASPM	3.18e-03	93	59	3	PS50096
Domain	-	POU6F2 POU5F1	3.27e-03	27	59	2	1.10.260.40
Pathway	REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	ABCA6 ABCA10 ABCA9	1.81e-05	18	41	3	M524
Pathway	REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION	AP2A1 AP2A2	1.72e-04	7	41	2	M27044
Pathway	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	ABCF1 ABCA6 ABCA10 ABCA9	2.21e-04	103	41	4	M758
Pathway	KEGG_ABC_TRANSPORTERS	ABCA6 ABCA10 ABCA9	2.78e-04	44	41	3	M11911
Pathway	REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION	AP2A1 AP2A2	2.93e-04	9	41	2	M27011
Pathway	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	AP2A1 AP2A2	4.46e-04	11	41	2	MM14694
Pathway	REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS	TET2 POU5F1	5.35e-04	12	41	2	M48035
Pathway	REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2	AP2A1 AP2A2	5.35e-04	12	41	2	MM15163
Pathway	WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION	AP2A1 AP2A2 DPPA2 POU5F1	5.69e-04	132	41	4	M48110
Pathway	REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2	AP2A1 AP2A2	6.31e-04	13	41	2	M27415
Pathway	REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4	AP2A1 AP2A2	7.35e-04	14	41	2	MM15161
Pathway	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	AP2A1 AP2A2	7.35e-04	14	41	2	M10122
Pathway	REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4	AP2A1 AP2A2	8.46e-04	15	41	2	M27413
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	ATRX NSD1 BRD1	8.80e-04	65	41	3	M39682
Pathway	REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION	AP2A1 AP2A2	9.65e-04	16	41	2	M27761
Pathway	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	AP2A1 AP2A2	9.65e-04	16	41	2	MM15048
Pathway	REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION	AP2A1 AP2A2	9.65e-04	16	41	2	MM15506
Pathway	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	AP2A1 AP2A2	1.09e-03	17	41	2	M5488
Pathway	REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	ABCA6 ABCA9	1.09e-03	17	41	2	MM14552
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	ABCF1 AP2A1 AP2A2 NALCN ABCA6 ABCA10 ABCA9 SLC27A4	1.09e-03	736	41	8	M27287
Pathway	REACTOME_LDL_CLEARANCE	AP2A1 AP2A2	1.23e-03	18	41	2	MM15565
Pathway	REACTOME_LDL_CLEARANCE	AP2A1 AP2A2	1.37e-03	19	41	2	M27846
Pathway	REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	AP2A1 AP2A2	1.67e-03	21	41	2	M12347
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CDCA2 MYH9 RPL38 AP2A1 ATRX RSL1D1 ACTR6 PHF12 PARP2 NSD1 DCLRE1A TTF1 THAP1 TOP1 SF3B2 SLC27A4 HOMEZ	9.08e-11	1294	63	17	30804502
Pubmed	Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.	ABCF1 RSL1D1 JADE1 TTF1 TOP1	5.90e-08	56	63	5	26919559
Pubmed	Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.	ABCF1 ABCA6 ABCA10 ABCA9	6.98e-08	22	63	4	8894702
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CDCA2 MYH9 RARRES1 AP2A1 AP2A2 ATRX IQGAP2 RSL1D1 DPPA2 XRN1 ASPM DNAH6 TOP1 SLC27A4	2.32e-07	1442	63	14	35575683
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYH9 ABCF1 RPL38 RSL1D1 XRN1 NSD1 TTF1 TOP1 SF3B2 PCM1	2.65e-07	653	63	10	22586326
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	CDCA2 MYH9 ABCF1 XRN1 ASPM SF3B2 PCM1	4.20e-07	256	63	7	33397691
Pubmed	The human ATP-binding cassette (ABC) transporter superfamily.	ABCA6 ABCA10 ABCA9	6.74e-07	10	63	3	11435397
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 MYH9 RPL38 PHF12 XRN1 POU5F1 PCM1 HOMEZ	8.85e-07	418	63	8	34709266
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	MYH9 ABCF1 AP2A1 AP2A2 RSL1D1 PARP2 TOP1 SLC27A4	2.71e-06	486	63	8	30940648
Pubmed	Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins).	AP2A1 AP2A2	3.23e-06	2	63	2	2564002
Pubmed	Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.	AP2A1 AP2A2	3.23e-06	2	63	2	12036598
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MYH9 ABCF1 RNMT AP2A2 IQGAP2 RSL1D1 XRN1 TOP1	3.24e-06	498	63	8	36634849
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CDCA2 MYH9 ABCF1 RPL38 AP2A1 AP2A2 RSL1D1 XRN1 ASPM TOP1 SF3B2 SLC27A4	4.86e-06	1353	63	12	29467282
Pubmed	Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.	AP2A1 AP2A2 PIK3C2B	5.38e-06	19	63	3	31959764
Pubmed	The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.	ATRX PARP2 TOP1	5.38e-06	19	63	3	20504901
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	ABCF1 RPL38 RSL1D1 DPPA2 POU5F1 TOP1 CC2D2B	7.52e-06	396	63	7	26687479
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CDCA2 MYH9 ABCF1 RPL38 AP2A1 AP2A2 ATRX RSL1D1 GALNT5 TOP1 SF3B2 SLC27A4	8.22e-06	1425	63	12	30948266
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	CDCA2 ABCF1 AP2A1 IQGAP2 RSL1D1 XRN1 ASPM TTF1 TOP1	8.85e-06	759	63	9	35915203
Pubmed	Clathrin-independent endocytic retrieval of SV proteins mediated by the clathrin adaptor AP-2 at mammalian central synapses.	AP2A1 AP2A2	9.68e-06	3	63	2	35014951
Pubmed	A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2.	AP2A1 AP2A2	9.68e-06	3	63	2	18032517
Pubmed	AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function.	AP2A1 AP2A2	9.68e-06	3	63	2	22262466
Pubmed	Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.	AP2A1 AP2A2	9.68e-06	3	63	2	26269175
Pubmed	A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex.	AP2A1 AP2A2	9.68e-06	3	63	2	19129443
Pubmed	Interaction of Shc with adaptor protein adaptins.	AP2A1 AP2A2	9.68e-06	3	63	2	8617812
Pubmed	Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development.	DPPA2 POU5F1	9.68e-06	3	63	2	18467432
Pubmed	Oct4 and the small molecule inhibitor, SC1, regulates Tet2 expression in mouse embryonic stem cells.	TET2 POU5F1	9.68e-06	3	63	2	23254757
Pubmed	The ear of alpha-adaptin interacts with the COOH-terminal domain of the Eps 15 protein.	AP2A1 AP2A2	9.68e-06	3	63	2	8662627
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CDCA2 ZNF567 ATRX PHF12 NSD1 BRD1 TOP1 HOMEZ	1.39e-05	608	63	8	36089195
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	AP2A1 AP2A2 PIK3C2B XRN1 PCM1	1.43e-05	169	63	5	31462741
Pubmed	The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.	AP2A1 AP2A2	1.93e-05	4	63	2	12646615
Pubmed	A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.	ABCA6 ABCA10	1.93e-05	4	63	2	25294155
Pubmed	Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate.	AP2A1 AP2A2	1.93e-05	4	63	2	20500056
Pubmed	Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.	TET2 POU5F1	1.93e-05	4	63	2	21295276
Pubmed	Association and colocalization of Eps15 with adaptor protein-2 and clathrin.	AP2A1 AP2A2	1.93e-05	4	63	2	9049247
Pubmed	Protein array based interactome analysis of amyloid-β indicates an inhibition of protein translation.	ABCF1 RSL1D1 PHF7 TSLP THAP1 SF3B2	1.93e-05	305	63	6	21244100
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CDCA2 AP2A1 RSL1D1 ACTR6 PARP2 XRN1 BRD1 PCM1	2.11e-05	645	63	8	25281560
Pubmed	FCH domain only-2 organizes clathrin-coated structures and interacts with Disabled-2 for low-density lipoprotein receptor endocytosis.	AP2A1 AP2A2 SF3B2	2.46e-05	31	63	3	22323290
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	ABCF1 PARP2 GREM1 TOP1 CREB3L1 MMUT	2.58e-05	321	63	6	32098917
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	RSL1D1 BRD1 SUCO TOP1 SF3B2 HOMEZ	3.01e-05	330	63	6	33301849
Pubmed	Weak Molecular Interactions in Clathrin-Mediated Endocytosis.	AP2A1 AP2A2	3.22e-05	5	63	2	29184887
Pubmed	A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein.	AP2A1 AP2A2	3.22e-05	5	63	2	17108326
Pubmed	Defects in dosage compensation impact global gene regulation in the mouse trophoblast.	ATRX POU5F1	3.22e-05	5	63	2	28684628
Pubmed	Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes.	ABCA6 ABCA9	3.22e-05	5	63	2	12532264
Pubmed	Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis.	AP2A1 AP2A2	3.22e-05	5	63	2	9723620
Pubmed	The bHLH transcription factor dHAND controls Sonic hedgehog expression and establishment of the zone of polarizing activity during limb development.	PRRX1 GREM1	3.22e-05	5	63	2	10804186
Pubmed	Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line.	DPPA2 POU5F1	3.22e-05	5	63	2	16990585
Pubmed	Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2.	AP2A1 AP2A2	3.22e-05	5	63	2	16139856
Pubmed	Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations.	AP2A1 AP2A2	3.22e-05	5	63	2	31671891
Pubmed	Analysis of the AP-2 adaptor complex and cargo during clathrin-mediated endocytosis.	AP2A1 AP2A2	3.22e-05	5	63	2	15941406
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	RSL1D1 PHF12 ASPM TTF1 PCM1	4.05e-05	210	63	5	16565220
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MYH9 ABCF1 AP2A1 AP2A2 SF3B2	4.53e-05	215	63	5	35973513
Pubmed	Human transcription factor protein interaction networks.	CDCA2 TET2 ATRX RSL1D1 ACTR6 PHF12 XRN1 TOP1 PCM1 HOMEZ SENP5	4.68e-05	1429	63	11	35140242
Pubmed	Calcyon, a mammalian specific NEEP21 family member, interacts with adaptor protein complex 3 (AP-3) and regulates targeting of AP-3 cargoes.	AP2A1 AP2A2	4.82e-05	6	63	2	22650988
Pubmed	Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium.	AP2A1 AP2A2	4.82e-05	6	63	2	22713487
Pubmed	The mu2 subunit of the clathrin adaptor AP-2 binds to FDNPVY and YppØ sorting signals at distinct sites.	AP2A1 AP2A2	4.82e-05	6	63	2	12121421
Pubmed	Clathrin.	AP2A1 AP2A2	4.82e-05	6	63	2	10966473
Pubmed	Molecular architecture and functional model of the endocytic AP2 complex.	AP2A1 AP2A2	4.82e-05	6	63	2	12086608
Pubmed	HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses.	AP2A1 AP2A2	4.82e-05	6	63	2	15020715
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	MYH9 ABCF1 RPL38 AP2A2 USP9Y TOP1 SF3B2 SLC27A4	4.84e-05	725	63	8	27025967
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	MYH9 ABCF1 RPL38 AP2A1 AP2A2 RSL1D1 PARP2 TOP1 SF3B2	5.10e-05	949	63	9	36574265
Pubmed	The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.	CDCA2 IQGAP2 PIK3C2B XRN1 ASPM	5.85e-05	227	63	5	26410627
Pubmed	Alpha-AP-2 directs myosin VI-dependent endocytosis of cystic fibrosis transmembrane conductance regulator chloride channels in the intestine.	AP2A1 AP2A2	6.74e-05	7	63	2	20351096
Pubmed	Clathrin interacts specifically with amphiphysin and is displaced by dynamin.	AP2A1 AP2A2	6.74e-05	7	63	2	9280305
Pubmed	Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein.	AP2A1 AP2A2	6.74e-05	7	63	2	7671305
Pubmed	Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta.	AP2A1 AP2A2	6.74e-05	7	63	2	16103193
Pubmed	Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.	AP2A1 AP2A2	6.74e-05	7	63	2	23676497
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CDCA2 MYH9 RPL38 RNMT RSL1D1 PARP2 TOP1 SF3B2 SLC27A4	7.00e-05	989	63	9	36424410
Pubmed	Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.	AP2A1 AP2A2	8.98e-05	8	63	2	2014052
Pubmed	Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice.	AP2A1 AP2A2	8.98e-05	8	63	2	11879655
Pubmed	beta-Catenin is a Nek2 substrate involved in centrosome separation.	MYH9 ASPM	8.98e-05	8	63	2	18086858
Pubmed	Identification of potential nuclear reprogramming and differentiation factors by a novel selection method for cloning chromatin-binding proteins.	ATRX NSD1	8.98e-05	8	63	2	15522233
Pubmed	Imprinted gene dysregulation in a Tet1 null mouse model is stochastic and variable in the germline and offspring.	TET2 POU5F1	8.98e-05	8	63	2	29530881
Pubmed	Accessory protein recruitment motifs in clathrin-mediated endocytosis.	AP2A1 AP2A2	1.15e-04	9	63	2	12057195
Pubmed	Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1.	ATRX NSD1	1.15e-04	9	63	2	24412544
Pubmed	Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity.	TSLP SLC27A4	1.15e-04	9	63	2	18507503
Pubmed	Doublecortin interacts with mu subunits of clathrin adaptor complexes in the developing nervous system.	AP2A1 AP2A2	1.15e-04	9	63	2	11591131
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	MYH9 ABCF1 RPL38 AP2A1 AP2A2 RSL1D1 PARP2 TTF1 TOP1 SF3B2	1.21e-04	1318	63	10	30463901
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	MYH9 ABCF1 RPL38 RSL1D1 XRN1 SF3B2	1.21e-04	425	63	6	21081503
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	MYH9 AP2A1 AP2A2 PIK3C2B USP9Y	1.23e-04	266	63	5	19380743
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MYH9 AP2A1 AP2A2 RSL1D1 PCM1	1.28e-04	268	63	5	33024031
Pubmed	CIN85 interacting proteins in B cells-specific role for SHIP-1.	MYH9 AP2A1 AP2A2	1.32e-04	54	63	3	21725061
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	MYH9 RPL38 AP2A1 IQGAP2 RSL1D1 TOP1 PCM1	1.37e-04	626	63	7	33644029
Pubmed	Localization of new genes and markers to the distal part of the human major histocompatibility complex (MHC) region and comparison with the mouse: new insights into the evolution of mammalian genomes.	POU5F1 MMUT	1.44e-04	10	63	2	7782091
Pubmed	CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature.	AP2A1 AP2A2	1.44e-04	10	63	2	25898166
Pubmed	HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2.	AP2A1 AP2A2	1.44e-04	10	63	2	17581864
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	MYH9 ABCF1 RPL38 TOP1 SF3B2	1.73e-04	286	63	5	32041737
Pubmed	Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome.	AP2A1 AP2A2	1.76e-04	11	63	2	31388001
Pubmed	Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.	POU5F1 TTF1	1.76e-04	11	63	2	22167068
Pubmed	HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.	AP2A1 AP2A2	1.76e-04	11	63	2	19802344
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TET2 MYH9 ABCF1 RPL38 RSL1D1 SF3B2 SENP5	1.81e-04	655	63	7	35819319
Pubmed	Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR.	MYH9 RPL38 AP2A1 AP2A2 RSL1D1	1.81e-04	289	63	5	37132043
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	MYH9 ABCF1 AP2A1 AP2A2	1.89e-04	156	63	4	22952844
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	MYH9 ABCF1 AP2A1 AP2A2 RSL1D1 TOP1 PCM1	1.89e-04	660	63	7	32780723
Pubmed	Essential role of Sox2 for the establishment and maintenance of the germ cell line.	POU5F1 TTF1	2.11e-04	12	63	2	23553930
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYH9 ABCF1 RPL38 AP2A1 AP2A2 IQGAP2 RSL1D1 TOP1 SF3B2	2.16e-04	1149	63	9	35446349
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH9 ABCF1 AP2A1 AP2A2 IQGAP2 CAMKV XRN1 DNAH6 TOP1 PCM1	2.36e-04	1431	63	10	37142655
Pubmed	Embryo-uterine interaction coordinates mouse embryogenesis during implantation.	MYH9 POU5F1	2.49e-04	13	63	2	37522872
Pubmed	Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.	AP2A1 AP2A2	2.49e-04	13	63	2	9882340
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	ABCF1 AP2A2 RSL1D1 ASPM TOP1	2.74e-04	316	63	5	31665637
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MYH9 ABCF1 ATRX RSL1D1 XRN1 TOP1 SF3B2 PCM1	2.75e-04	934	63	8	33916271
Interaction	EBF1 interactions	TET2 POU6F2 POU5F1 HOMEZ	1.76e-07	17	61	4	int:EBF1
Interaction	ABCA10 interactions	ABCA6 ABCA10 ABCA9	1.46e-06	8	61	3	int:ABCA10
Interaction	H2BC21 interactions	RGS6 ATRX ACTR6 PHF12 PARP2 DPPA2 NSD1 JADE1 BRD1 TTF1 TOP1	6.68e-06	696	61	11	int:H2BC21
Interaction	ZCCHC10 interactions	AP2A1 AP2A2 CAMKV DPPA2 ASPM THAP1 SF3B2	7.04e-06	236	61	7	int:ZCCHC10
Interaction	KPNA2 interactions	CDCA2 MYH9 RNMT IQGAP2 NPIPB6 POU5F1 BRD1 SF3B2 HOMEZ	2.45e-05	519	61	9	int:KPNA2
Interaction	H2BC9 interactions	CDCA2 MYH9 ABCF1 ATRX RSL1D1 NSD1 DNAH6 SENP5	5.70e-05	446	61	8	int:H2BC9
Interaction	KIF20A interactions	MYH9 ABCF1 RPL38 AP2A1 AP2A2 RSL1D1 XRN1 USP9Y THAP1 TOP1 SF3B2 PCM1	6.24e-05	1052	61	12	int:KIF20A
Interaction	PHLPP1 interactions	CDCA2 MYH9 ABCF1 XRN1 ASPM SF3B2 PCM1	6.41e-05	333	61	7	int:PHLPP1
Interaction	SIRT7 interactions	MYH9 ABCF1 RPL38 RSL1D1 XRN1 NSD1 TTF1 TOP1 SF3B2 PCM1	7.26e-05	744	61	10	int:SIRT7
Interaction	H1-5 interactions	IQGAP2 RSL1D1 PARP2 SLIT3 NSD1 POU5F1 CCDC168 SF3B2	7.40e-05	463	61	8	int:H1-5
Interaction	H3-3A interactions	CDCA2 ZNF567 MYH9 ATRX PARP2 NSD1 BRD1 TOP1 SF3B2 HOMEZ	7.67e-05	749	61	10	int:H3-3A
Interaction	TCEA2 interactions	POU6F2 MYH9 CAMKV THAP1 HOMEZ	1.20e-04	159	61	5	int:TCEA2
Interaction	RPL23AP32 interactions	RSL1D1 NSD1 TTF1 SF3B2	1.40e-04	87	61	4	int:RPL23AP32
Cytoband	Ensembl 112 genes in cytogenetic band chr17q24	ABCA6 ABCA10 ABCA9	3.41e-04	98	63	3	chr17q24
Cytoband	1q24	PRRX1 SUCO	3.47e-04	20	63	2	1q24
Cytoband	5q35	SLIT3 NSD1	4.60e-04	23	63	2	5q35
GeneFamily	PHD finger proteins	PHF12 NSD1 PHF7 JADE1 BRD1	1.05e-06	90	37	5	88
GeneFamily	ATP binding cassette subfamily A	ABCA6 ABCA10 ABCA9	2.83e-06	14	37	3	805
GeneFamily	PWWP domain containing	ZCWPW2 NSD1 BRD1	1.18e-05	22	37	3	1147
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT17 GALNT5	7.56e-04	20	37	2	433
GeneFamily	POU class homeoboxes and pseudogenes	POU6F2 POU5F1	1.00e-03	23	37	2	523
Coexpression	HAY_BONE_MARROW_STROMAL	POU6F2 PRRX1 GALNT17 RARRES1 NALCN ABCA6 SLIT3 BBOX1 ABCA10 ABCA9	1.37e-05	767	63	10	M39209
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	CDCA2 MYH9 ABCF1 ATRX IQGAP2 ASPM NSD1 SUCO	7.01e-06	339	63	8	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9 CREB3L1	1.04e-08	192	63	7	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 GREM1 ABCA10 ABCA9	1.12e-08	194	63	7	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	Control-Stromal-Fibroblast\|Control / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA10 ABCA9	1.20e-08	196	63	7	7ca94477498a84cafcdd9933ee92a6cbde76c70e
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRRX1 GALNT17 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	1.20e-08	196	63	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	PRRX1 GALNT17 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	1.25e-08	197	63	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	PRRX1 GALNT17 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	1.29e-08	198	63	7	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	PRRX1 GALNT17 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	1.29e-08	198	63	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 GALNT17 ABCA6 SLIT3 DPPA2 ABCA9	9.46e-08	157	63	6	f147e24f2ece82e1c54750868954d09b3c461804
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	1.41e-07	168	63	6	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 ABCA10 ABCA9 CREB3L1	1.41e-07	168	63	6	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	1.80e-07	175	63	6	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 GALNT17 NALCN ABCA6 ABCA10 ABCA9	1.92e-07	177	63	6	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 GALNT17 NALCN ABCA6 ABCA10 ABCA9	1.92e-07	177	63	6	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	2.05e-07	179	63	6	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	2.41e-07	184	63	6	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	2.41e-07	184	63	6	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	2.49e-07	185	63	6	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	2.49e-07	185	63	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	GALNT17 NALCN ABCA6 SLIT3 ABCA10 ABCA9	2.65e-07	187	63	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	2.92e-07	190	63	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	2.92e-07	190	63	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	2.92e-07	190	63	6	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 RARRES1 ABCA6 SLIT3 GREM1 ABCA9	3.01e-07	191	63	6	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.01e-07	191	63	6	4e4488380379ed29d7898bae4e24221e7c67eb9d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.10e-07	192	63	6	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.10e-07	192	63	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.10e-07	192	63	6	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 RARRES1 ABCA6 SLIT3 GREM1 ABCA9	3.20e-07	193	63	6	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	PRRX1 GALNT17 RARRES1 ABCA6 SLIT3 ABCA9	3.20e-07	193	63	6	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.20e-07	193	63	6	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RARRES1 ABCA6 SLIT3 JADE1 ABCA10 ABCA9	3.20e-07	193	63	6	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	PRRX1 NALCN ABCA6 SLIT3 GREM1 ABCA9	3.29e-07	194	63	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.29e-07	194	63	6	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	PRRX1 GALNT17 ZCWPW2 ABCA6 SLIT3 ABCA9	3.29e-07	194	63	6	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	3.29e-07	194	63	6	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.40e-07	195	63	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA9	3.40e-07	195	63	6	9c32756edb54f0c211185d9a98073fe01fd1526a
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.40e-07	195	63	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	3.40e-07	195	63	6	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRRX1 ATRX ABCA6 XRN1 ABCA9 PCM1	3.40e-07	195	63	6	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	IPF-Stromal-Fibroblast\|IPF / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA9	3.50e-07	196	63	6	f7ae604ba32b322d86d68b2b54892e7c6ab06c49
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.50e-07	196	63	6	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.50e-07	196	63	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Control-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA9	3.50e-07	196	63	6	1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	3.60e-07	197	63	6	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 SLIT3 ABCA10 ABCA9	3.60e-07	197	63	6	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 ABCA6 SLIT3 JADE1 ABCA10 ABCA9	3.71e-07	198	63	6	abac765c4f6864bdb1700bc546c3b9771edc25c3
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRRX1 GALNT17 RARRES1 ABCA6 SLIT3 ABCA9	3.71e-07	198	63	6	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COPD-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA9	3.71e-07	198	63	6	2f13c0b3372af53d1bd85f9546f315c878580a71
ToppCell	Control-Stromal\|Control / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA9	3.71e-07	198	63	6	ae726b6b7f0a4107899be4d32ac256ffa0bd8d59
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.71e-07	198	63	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	3'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 ABCA6 SLIT3 JADE1 ABCA10 ABCA9	3.71e-07	198	63	6	ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2
ToppCell	COPD-Stromal-Fibroblast\|COPD / Disease state, Lineage and Cell class	PRRX1 RARRES1 ZCWPW2 ABCA6 SLIT3 ABCA9	3.71e-07	198	63	6	7904af61473cb20064f7a3a1e1bfe8d5913cf317
ToppCell	3'-Adult-LymphNode-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 ABCA6 SLIT3 JADE1 ABCA10 ABCA9	3.71e-07	198	63	6	698166b4ca173176ed563af6a1efc8c7d0a18e0b
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	PRRX1 GALNT17 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	f835e7ffe976843b0edbf695762d463da85793f3
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	4e128c705ad36fd840582848f278770f356fcc8b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	a538da095ba996ee96e263442cf5b6ba9178f3d4
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	4032f03a4165f5f2a90ef1d8315cc743ce9075bb
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	0019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.82e-07	199	63	6	993fa050a095017135a6e723c77cd38b9d782e58
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	8d75ce89393df452defacf2ec9a5bd4b7708afbb
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	0b2614b8513693dd508c9003699049efd9abac52
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	28e5354008adf97b17333f17f8cbef930db6729a
ToppCell	Biopsy_Other_PF-Mesenchymal-Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	9996b6887cf2b1936e10a1aa396f09fd8da5f4c4
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	17ffdbc13332bd3ed1d54abcd7af20267dd4b234
ToppCell	367C-Fibroblasts-Fibroblast-E-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	57b9d6aa2265ab178a5886f36ecc66115bd382a8
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	fc3c4778841c4b8bac0afb458352614b2c460617
ToppCell	Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	0aa316b71f195ecf17ee897e307f8928a755a637
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 RNMT ATRX XRN1 ANKRD12 PCM1	3.94e-07	200	63	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	665df8391d2ebcfc6536318612f4992852b5e2b8
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	8d2ceb2080c67b20f452eeca605aa27a58033c04
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	6e3d1ae0ef84d3075afa40129a41169996462672
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	ef30f9b68bfdb8d947ed399603e4dd0d5ff0144d
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	9dd2eb70c1cc146935f5aff27373dfc65cb8c098
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYH9 RNMT IQGAP2 XRN1 ANKRD12 TOP1	3.94e-07	200	63	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	6b48ddde83bc6c941d557844aa214d4d2c8e736d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	b28bfe6eb96b4db9cb27f0fc8fc39259c125f05e
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	5fdca7959134a5c8e06e5d6d14aafe34b963aef2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	5c6520dc4c4693827f6680651785680b5883afb8
ToppCell	367C-Fibroblasts-Fibroblast-E\|367C / Donor, Lineage, Cell class and subclass (all cells)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	ddfbc004e7bd2fd3f11f046ed8fc049277160547
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	c338a08c1605527ab9aaf62ea151a19e8469dc6d
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	56536236a7012efdb28f85b40e464f3da3e87ce8
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA10 ABCA9	3.94e-07	200	63	6	87953ea65ff2a01485e13dd49d993ae6ae679cbf
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRRX1 ABCA6 SLIT3 DPPA2 ABCA9	2.99e-06	158	63	5	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	POU6F2 MYH9 IQGAP2 CCDC168 ANKRD12	3.08e-06	159	63	5	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D231\|Adult / Lineage, Cell type, age group and donor	GALNT17 RARRES1 NALCN ABCA6 ABCA9	3.59e-06	164	63	5	3d8ff70fe5582d1fb56b338be8b76fa1428b3657
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 NALCN ABCA6 ABCA10 ABCA9	4.40e-06	171	63	5	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA9	5.06e-06	176	63	5	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX XRN1 NSD1 ABCA9 PCM1	5.06e-06	176	63	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZCWPW2 ABCA6 SLIT3 PHF7 ABCA10	5.06e-06	176	63	5	b4a23d8d1414434adeb237a96f28c825f1aebd77
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZCWPW2 ABCA6 SLIT3 PHF7 ABCA10	5.06e-06	176	63	5	66c9c6b59030f67e8d746a9c6930e50923f2ded1
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	PRRX1 RARRES1 ABCA6 SLIT3 ABCA9	5.06e-06	176	63	5	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	POU6F2 GALNT17 RGS6 ASPM DNAH6	5.50e-06	179	63	5	c815eb9f760fe4ca7a5e49beb224659f0b864f22
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	POU6F2 PRRX1 RGS6 SLIT3 DNAH6	5.50e-06	179	63	5	065a50952e8703fa07767beb6b73a090bf378ca6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRRX1 RARRES1 SLIT3 GREM1 ABCA9	5.65e-06	180	63	5	c2746092ef251e9d5910fe96461afdd0624a24c6
Disease	Adenoid Cystic Carcinoma	ATRX ASPM NSD1 BRD1	6.34e-05	100	63	4	C0010606
Disease	hepatocyte growth factor receptor measurement	RNMT ABCA6	9.36e-05	7	63	2	EFO_0008153
Disease	microcephaly (is_implicated_in)	ASPM NSD1	1.25e-04	8	63	2	DOID:10907 (is_implicated_in)
Disease	leptin measurement, sex interaction measurement	SLIT3 ABCA9	2.00e-04	10	63	2	EFO_0005000, EFO_0008343
Disease	tonsillectomy risk measurement	TET2 PRRX1 NPIPB8 RSL1D1 POU5F1	2.37e-04	260	63	5	EFO_0007924
Disease	schizophrenia, sex interaction measurement	ABCA6 GALNT5 ABCA9	2.91e-04	60	63	3	EFO_0008343, MONDO_0005090
Disease	Colorectal Neoplasms	TET2 ABCA6 GREM1 ABCA10 ABCA9	3.17e-04	277	63	5	C0009404
Disease	corneal resistance factor	TET2 PRRX1 ABCA6 ABCA10 ABCA9 TOP1	4.01e-04	451	63	6	EFO_0010067
Disease	central corneal thickness	TET2 PRRX1 ABCA6 ABCA10 TOP1	5.22e-04	309	63	5	EFO_0005213
Disease	corneal hysteresis	ABCA6 ABCA10	8.32e-04	20	63	2	EFO_0010066
Disease	C-reactive protein measurement	RNMT RGS6 ABCA6 CAMKV MIB2 CCDC168 TOP1 CREB3L1 SF3B2	1.00e-03	1206	63	9	EFO_0004458
Disease	remnant cholesterol measurement	ABCA6 ABCA10 TOP1	1.61e-03	108	63	3	EFO_0010815
Disease	upper respiratory tract disorder	TET2 TSLP	1.64e-03	28	63	2	MONDO_0004867
Disease	Hematopoetic Myelodysplasia	TET2 ATRX	1.76e-03	29	63	2	C2713368
Disease	free cholesterol measurement	ABCA6 ABCA10 TOP1	1.84e-03	113	63	3	EFO_0008591
Disease	response to candesartan	PRRX1 GALNT17	2.00e-03	31	63	2	GO_1901556

Protein segments in the cluster

Peptide	Gene	Start	Entry
QSQITRRKKRKKDFQ	TTF1	46	Q15361
CRSKKKKEAIIRINV	ACTR6	161	Q9GZN1
KEALTRKQQKCRRKN	ABCF1	576	Q8NE71
CLRTKRHKNNRVKKK	BRD1	86	O95696
RKIKNKISAQESRRK	CREB3L1	296	Q96BA8
RKKKIAIRNVSFCVK	ABCA10	1216	Q8WWZ4
SKRKKKIATRNVSFC	ABCA9	1301	Q8IUA7
KRKKKIAARNISFCV	ABCA6	1296	Q8N139
RNCKSKEAEIKRINK	AP2A1	21	O95782
KIKQKEKERLRNRNC	ANKRD12	1101	Q6UB98
KCSLHEQKRRAKIQK	CC2D2B	486	Q6DHV5
RKKNDCTKIKAIRLS	ASPM	3221	Q8IZT6
RNCKSKEAEIKRINK	AP2A2	21	O94973
NTVNRKALKTERKRK	NSD1	1041	Q96L73
DIRKCRRLKNPQKVK	RGS6	216	P49758
AKKTRRCQRQESKKM	PARP2	36	Q9UGN5
KKKRVTRVKQCRCIS	GREM1	166	O60565
NSITVKQRCKRKIEA	PCM1	1696	Q15154
VRAKIRKRKVTTKIN	NPIPB8	171	E9PQR5
KKRLKQCNVITRLRG	GDPD4	146	Q6W3E5
QAACKQVRRTEKKLK	MYH9	1831	P35579
CKAETLVQARKRKRT	POU5F1	221	Q01860
QKTTKRKTKVARKTC	PIK3C2B	1551	O00750
QKKKRRRIKVQEDSS	ATRX	1421	P46100
RKNVRSKKITGCQKS	DNAH6	286	Q9C0G6
TCKKFQKRDGRKVRK	CAMKV	51	Q8NCB2
NLTQQRELRKKLKCK	GALNT5	776	Q7Z7M9
KVKCAKRQKTVVRVR	LINC00305	56	Q7Z4B0
LKKRCFSKQARAKLQ	BBOX1	91	O75936
VSERRALRKSLKCKN	GALNT17	431	Q6IS24
KTSVCRQVDIARKRK	RNMT	46	O43148
KINRRKSQETKCTKR	CDCA2	536	Q69YH5
LSSERSQRQKKRCRK	DCLRE1A	626	Q6PJP8
RQRKTKRKTKEQLAI	HOMEZ	356	Q8IX15
KINRESTRKHRKKCK	CCDC168	2311	Q8NDH2
VRAKIRKRKVTTKIN	NPIPB6	171	E9PJ23
KLRVVQISRKECAKR	PRSS51	146	A0A1B0GVH4
TRLQRCSRKRKAVTK	DPPA2	141	Q7Z7J5
KKCIRCQVVVSKKLR	MIB2	861	Q96AX9
EKKECQRLRKSAKTR	PHF7	6	Q9BWX1
KKNKDNVKFKVRCSR	RPL38	26	P63173
IKTCLDNLKRKNTRR	IQGAP2	1446	Q13576
CNKRQALKNTIKRLK	POU6F2	656	P78424
RCTVRRKKREQKKEL	PHF12	101	Q96QT6
RREKIKRSVCKVQEQ	JADE1	511	Q6IE81
ANKRISQIKSKKFRC	SLIT3	471	O75094
NKKRRATNIEKKHTC	ZNF567	241	Q8N184
VSVSKKEKNRKRRNR	SF3B2	316	Q13435
FRTKSKVCKLRKAQR	SENP5	251	Q96HI0
ERKKKRQQARKTASV	RSL1D1	301	O76021
KVKAKVRQCLQERRT	SLC27A4	61	Q6P1M0
VEKLRKKLKTAQQRC	THAP1	156	Q9NVV9
KKLKTAQQRCRRQER	THAP1	161	Q9NVV9
KCKQRKNNKKVRVTV	XRN1	1066	Q8IZH2
KRRKRKVTTNKCLEQ	TSLP	126	Q969D9
KAVNCRERKLIAKRR	USP9Y	746	O00507
QSQKTKTEKRALKRR	SUCO	1191	Q9UBS9
KRKRKAILKCSFENV	ZCWPW2	236	Q504Y3
SEEKKKRKQRRNRTT	PRRX1	86	P54821
VKTCRQRKLEAKKAA	TET2	1461	Q6N021
INVTCTRLIEKKKRQ	RARRES1	141	P49788
TARRLKKCVDKIRNQ	TOP1	446	P11387
LKKCLKRIRAKQQQS	NALCN	1576	Q8IZF0
RNRQIEKLKKIKSSR	MMUT	511	P22033